Exagen Inc (NQ: XGN )
3.120
+0.070
(+2.30%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Exagen Inc
![](https://ml.globenewswire.com/media/9941b537-44e2-4292-b9b5-39b5a50e49be/small/exagen-full-cmyk-print-notagline-3-15-24-png.png)
![](https://ml.globenewswire.com/media/9941b537-44e2-4292-b9b5-39b5a50e49be/small/exagen-full-cmyk-print-notagline-3-15-24-png.png)
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/9941b537-44e2-4292-b9b5-39b5a50e49be/small/exagen-full-cmyk-print-notagline-3-15-24-png.png)
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
August 01, 2024
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/9941b537-44e2-4292-b9b5-39b5a50e49be/small/exagen-full-cmyk-print-notagline-3-15-24-png.png)
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/9941b537-44e2-4292-b9b5-39b5a50e49be/small/exagen-full-cmyk-print-notagline-3-15-24-png.png)
![](https://ml.globenewswire.com/media/9941b537-44e2-4292-b9b5-39b5a50e49be/small/exagen-full-cmyk-print-notagline-3-15-24-png.png)
![](https://ml.globenewswire.com/media/9941b537-44e2-4292-b9b5-39b5a50e49be/small/exagen-full-cmyk-print-notagline-3-15-24-png.png)
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/9941b537-44e2-4292-b9b5-39b5a50e49be/small/exagen-full-cmyk-print-notagline-3-15-24-png.png)
Exagen Inc. Announces Changes to the Board of Directors
April 26, 2024
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/9941b537-44e2-4292-b9b5-39b5a50e49be/small/exagen-full-cmyk-print-notagline-3-15-24-png.png)
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
January 07, 2024
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Exagen Inc. Reports Strong Third Quarter 2023 Results
November 13, 2023
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
September 28, 2023
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 12, 2023
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Exagen Inc. Reports Strong Second Quarter 2023 Results
August 07, 2023
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Exagen Inc. Appoints Paul Kim to Board of Directors
July 24, 2023
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.